Literature DB >> 18490213

Elevated perioperative transaminase level predicts intrahepatic recurrence in hepatitis B-related hepatocellular carcinoma after curative hepatectomy.

Yue-Sun Cheung1, Henry L Y Chan, John Wong, Kit-Fai Lee, Terence C W Poon, Nathalie Wong, Paul B S Lai.   

Abstract

OBJECTIVE: We aimed to evaluate the role of elevated perioperative alanine aminotransferase (ALT) as a surrogate marker of hepatitis activity in determining the risk of recurrence and survival in hepatitis B-related hepatocellular carcinoma (HCC) after curative hepatectomy.
METHODS: A retrospective review of the hepatectomy database was performed and 142 patients were found who had hepatitis B-related HCC from January 2001 to March 2006. Their ALT levels preoperatively and 1 month, 3 months, and 6 months postoperatively were recorded. The risk factors for recurrence and prognostic factors of survival were analysed.
RESULTS: An elevated perioperative ALT level (p = 0.021), multiple tumour nodules in the resected specimen (p < 0.001), and a tumour size greater than 5 cm (p = 0.001) were significant independent risk factors for tumour recurrence. The latter two factors were also independent prognostic factors for overall survival and disease-free survival. An elevated ALT level was an independent prognostic factor for disease-free survival (p = 0.025).
CONCLUSION: An elevated perioperative ALT level, which reflects increased hepatitis activity, is an independent risk factor for intrahepatic recurrence of hepatitis B-related HCC. It is also associated with a poorer disease-free survival rate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490213     DOI: 10.1016/S1015-9584(08)60056-1

Source DB:  PubMed          Journal:  Asian J Surg        ISSN: 1015-9584            Impact factor:   2.767


  16 in total

1.  Impact of Preoperative Hepatitis B Virus Levels on Prognosis After Primary and Repeat Hepatectomies for Hepatocellular Carcinoma Patients-a Retrospective Study.

Authors:  Pin-Gao Yan; Ruo-Yu Wang; Jin Zhang; Wen-Ming Cong; Hui Dong; Hong-Yu Yu; Wan Yee Lau; Meng-Chao Wu; Wei-Ping Zhou
Journal:  J Gastrointest Surg       Date:  2018-01-08       Impact factor: 3.452

Review 2.  Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review.

Authors:  Jian-Hong Zhong; Qing-Lian Zhong; Le-Qun Li; Hang Li
Journal:  Tumour Biol       Date:  2014-08-14

3.  mPGES-1 expression in non-cancerous liver tissue impacts on postoperative recurrence of HCC.

Authors:  Koichi Nonaka; Hikaru Fujioka; Yasushi Takii; Seigo Abiru; Kiyoshi Migita; Masahiro Ito; Takashi Kanematsu; Hiromi Ishibashi
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

Review 4.  Nucleos(t)ide analogs in the prevention of hepatitis B virus related hepatocellular carcinoma.

Authors:  Bulent Baran
Journal:  World J Hepatol       Date:  2015-07-08

5.  Serum alanine aminotransferase to hemoglobin ratio and radiological features predict the prognosis of postoperative adjuvant TACE in patients with hepatocellular carcinoma.

Authors:  Zicong Xia; Yulou Zhao; Hui Zhao; Jing Zhang; Cheng Liu; Wenwu Lu; Lele Wang; Kang Chen; Junkai Yang; Jiahong Zhu; Wenjing Zhao; Aiguo Shen
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738

6.  Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation.

Authors:  Min-Jie Ju; Shuang-Jian Qiu; Jia Fan; Jian Zhou; Qiang Gao; Ming-Yan Cai; Yi-Wei Li; Zhao-You Tang
Journal:  J Gastroenterol       Date:  2009-04-22       Impact factor: 7.527

Review 7.  Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma.

Authors:  Charing Ching Ning Chong; Grace Lai Hung Wong; Paul Bo San Lai
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

8.  Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.

Authors:  Sheng-Li Yang; Li-Ping Liu; Yun-Fan Sun; Xing-Rong Yang; Jia Fan; Jian-Wei Ren; George G Chen; Paul B S Lai
Journal:  J Gastroenterol       Date:  2015-11-25       Impact factor: 7.527

9.  Impact of Postoperative Complications on Long-Term Survival After Resection of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Junjie Kong; Guangbing Li; Jiawei Chai; Guangsheng Yu; Yong Liu; Jun Liu
Journal:  Ann Surg Oncol       Date:  2021-06-23       Impact factor: 5.344

10.  Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy.

Authors:  Yang Ke; Liang Ma; Xue-Mei You; Sheng-Xin Huang; Yong-Rong Liang; Bang-De Xiang; Le-Qun Li; Jian-Hong Zhong
Journal:  Cancer Biol Med       Date:  2013-09       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.